Brucellosis: the case for live, attenuated vaccines.
(1/192)
(+info )Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease.
(2/192)
(+info )Dengue virus serotype 4, northeastern Peru, 2008.
(3/192)
(+info )Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population.
(4/192)
(+info )Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens.
(5/192)
(+info )Estimates of the transmissibility of the 1968 (Hong Kong) influenza pandemic: evidence of increased transmissibility between successive waves.
(6/192)
(+info )Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection.
(7/192)
(+info )Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?
(8/192)
(+info )